Binaural Music Study

NCT ID: NCT05240196

Last Updated: 2022-03-09

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 57 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2020-01-14
• Study Completion Date: 2020-03-31

Brief Summary

To evaluate client experience relating to mammography and pain scores for patients attending for annual surveillance mammography with a family history of breast cancer. It will involve face to face patient interviews with clients that have had previous mammography at the study site (Tameside and Glossop Integrated Care Trust). The data will be specific to the study site and gathered by the PI only. This is a feasibility study, the data will be used to inform further study across additional sites and application for a College of Radiographers grant. The study is a quantitative assessment of pain following the intervention of binaural music, the mammogram will be undertaken by the same mammographer to standardise technique. Pain will be assessed using a validated numerical 11 point pain score for ease of use as per previous published research.

Each client will feedback twice during the care event:

1. Retrospectively from previous experience

2. Actual pain, if any, during planned mammogram Patients will be randomised to the following groups;

1. Control 2. Binaural music 3. Non binaural music If the feasibility study is successful the study will proceed to a second phase and the number of participants extended to 60 patients per group (180 in total) and the study ceased when the number reached.

If there is an indication to extend to another Trust (multi-site trial). A new IRAS application will be submitted following the feasibility study, if successful.

Detailed Description

Principal aim of the study: To investigate whether the experience of mammography-related pain can be improved by listening to binaural music prior to the examination.

The research aims to improve patient experience for patients undergoing annual mammography with moderate or high risk of breast cancer. These patients can commence annual mammography at 40 years of age until entering the National Health Service Breast Screening Program (NHSBSP), (NICE, 2013). Reduction in pain or anxiety for these patients may improve compliance, reduce DNA rates which is a cost saving to the NHS.

Previously, mammography-related pain scores have been evaluated within the study institution in these groups of women by measuring pain using a VAS/NRS pain tool three times; before, immediately after and 1-week post mammography. The results of this study showed that expectation of pain by the patient was the only significant predictor for pain r=0.79. Breast size, compression force, menopausal status and breast density were not found to be significant indicators for pain (Nelson et al., 2018).

One of the action points for this research was to repeat the study within the introduction of a series of pain interventions to improve pain scores for all patients in the low, moderate and severe pain categories.

f. Methodology The feasibility study will be a prospective, randomised controlled trial enabling comparisons based on current pain measurements, for patients attending family history screening at Tameside and Glossop Integrated Care NHS Foundation Trust. If the results are significant then a larger scale study across 2-3 sites is planned.

The patient information sheet (PIS) will be posted with the appointment letter and the patients will have 2 weeks to read the letter and contact the researcher with any questions or concerns prior to their mammogram appointment.

Allocation to the group will be randomised prior to mammogram by selection using an online randomisation tool until the sample size is reached for each group (control, non binaural music, binaural music). The patients will be asked to participate in the study and will not know which group they are in until instructions are given just prior to the examination. The control group will be asked to score their pain before and after routine mammography without actively listening to music.

The patient will be asked to self-evaluate their pain from their most recent previous mammogram from memory using a validated 11-point numerical scale where zero = no pain and 10 = the worst pain. The patient will then be asked to score their pain following their current mammogram and this will be recorded on a second validated 11-point numerical scale (Yale 2018). The information will be recorded by the mammographer for improved consistency and scanned into the radiology information system as a permanent record. The same mammographer will perform the mammograms to standardise technique, the compression given will remain at her discretion. Music will be standardised and played using personal headphones for 5 minutes prior to mammography

Conditions

Pain

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: BASIC_SCIENCE
• Blinding Strategy: NONE

Study Groups

Control

participant will receive standard care only

Group Type: NO_INTERVENTION

No interventions assigned to this group

Binaural music

Participants will listen to binaural music whilst having a routine mammogram

Group Type: OTHER

music

Intervention Type: OTHER

playing binaural or non-binaural music

Non-binaural music

Participants will listen to non-binaural music whilst having a routine mammogram

Group Type: OTHER

music

Intervention Type: OTHER

playing binaural or non-binaural music

Interventions

music

playing binaural or non-binaural music

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Bilateral mammogram.
• Asymptomatic patients only.
• Patients attending for family history follow up mammography.
• Patients that have had a mammogram within 2 years at the trust to compare to on the same equipment.
• Patients with language barriers if an interpreter or relative is available.

Exclusion Criteria

• Patients with mammography elsewhere including screening units or in the private sector.

Family history patients having their 1st mammogram. Patients with breast implants. Patients with inability to consent due to mental incapacity. Patients with hearing impairments Patients with a history of epilepsy Patients with ongoing mental health illness Patients with heart arrhythmia and pacemakers Patients taking prescribed pain medication

• Minimum Eligible Age: 40 Years
• Maximum Eligible Age: 100 Years
• Eligible Sex: FEMALE
• Accepts Healthy Volunteers: No

Sponsors

University of Salford

OTHER

Sponsor Role: collaborator

Tameside General Hospital

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Debbie Nelson

Role: PRINCIPAL_INVESTIGATOR

Tameside and Glossop Integrated Care NHS Foundation Trust

Locations

Tameside and Glossop Integrated Care NHS Foundation Trust

Manchester, , United Kingdom

Countries

United Kingdom

Other Identifiers

BR/2019/487

Identifier Type: -

Identifier Source: org_study_id